Skip to main content
. 2025 Aug 26;25:425. doi: 10.1186/s12871-025-03285-7

Table 1.

Baseline and surgical characteristics

Group Total study population
(n = 67)
CPB
(n = 18)
m-CPB
(n = 15)
VV-ECMO
(n = 28)
VA-ECMO
(n = 6)
P value
Male gender, n (%) 30 (44.8) 8 7 12 3 0.71
Age (years), median (range) 47.3 (14–74) 44.5 (32–69) 46.7 (47–74) 49.2 (14–65) 51.6 (44–63) 0.53
Weight (kg), median [IQR] 62.3 [43.2–79.7] 58.4 [43.2–71.1] 63.7 [51.8–68.3] 66.5 [54.2–65.8] 63.7 [57.2–79.7] 0.67
BMI (kg/m2) [IQR] 24.4 [19.8–27.9] 25.1 [23.6–26.3] 25.8 [23.7–27.9] 24.6 [19.8–27.6] 25.3 [23.6–27.4] 0.54
FEV1% [IQR] 40.2 [28.3–63.6] 33.6 [28.3–48.6] 35.8 [29.6–52.3] 36.5 [31.6–63.6] 35.9 [28.4–50.7] 0.43
Stenosis rate > 90% 60(88.1) 16(88.9) 13(86.7) 27(96.4) 4(66.7) 0.41
Clinical presentation, n (%)
 Cough 34(50.7) 8(44.4) 7(46.7) 15(53.6) 4(66.7) 0.28
 Hemoptysis 18(26.9) 7(38.9) 5(33.3) 4(14.3) 2(33.3) 0.49
 Hoarse voice 12(17.8) 4(22.2) 2(13.3) 6(21.4) 0(0) 0.53
 Wheezing or stridor 23(34.3) 8(44.4) 6(40.0) 7(25.0) 2(33.3) 0.41
 Progressive dyspnea 29(43.3) 9(50.0) 7(46.7) 10(35.7) 3(50.0) 0.38
 Shortness of breath 34(50.7) 10(55.6) 9(60.0) 11(39.3) 4(66.7) 0.47
Comorbidities, n (%)
 Diabetes 11(16.4) 2(11.1) 3(20.0) 4(14.3) 2(33.3) 0.58
 Coronary artery disease 6(8.9) 2(11.1) 2(13.3) 1(3.6) 1(16.7) 0.34
 Hypertension 26(38.9) 6(33.3) 5(33.3) 12(42.9) 3(50.0) 0.43
 Cerebrovascular disease 3(4.5) 1(5.6) 0(0. 0) 2(7.1) 0(0.0) 0.38
 COPD 8(11.9) 2(11.1) 3(20.0) 3(10.7) 0(0.0) 0.52
 Peripheral vascular disease 4(6.0) 0(0.0) 0(0.0) 3(10.7) 1(16.7) 0.49
 Previous surgical history 3(4.5) 2(11.1) 1(6.7) 0(0. 0) 0(0. 0) 0.43
Diagnosis, n (%)
 Carcinoma 21(31.3) 5(27.8) 3(20.0) 8(28.6) 5(83.3) 0.62
 Carcinoid 13(19.4) 2(11.1) 4(26.7) 7(25.0) 0(0.0) 0.65
 Tracheal fistulas 12(17.9) 4(22.2) 3(20.0) 4(14.3) 1(16.7) 0.45
 Tracheal stenosis 18(26.9) 5(27.8) 4(26.7) 9(32.1) 0(0.0) 0.46
 Others 3(4.5) 2(11.1) 1(6.7) 0(0.0) 0(0.0) 0.51
Surgical approach, n (%)
 Median sternotomy 17(25.4) 6(33.3) 3(20.0) 6(21.4) 1(16.7) 0.21
 Posterolateral thoracotomy 41(61.2) 11(61.1) 10(66.7) 16(57.1) 5(83.3) 0.32
 VATS 9(13.4) 1(5.6) 2(13.3) 6(21.4) 0(0.0) 0.14
Resected site, n (%)
 Only primary trachea 29(43.4) 7(38.9) 6(40) 14(50) 2(33.3) 0.49
 Carina 38(56.7) 11(61.1) 9(60.0) 14(50.0) 4(66.7) 0.56
Type of resection, n (%)
 Carinal resection with neocarina 32(47.8) 8(44.4) 9(60.0) 11(39.3) 4(66.7) 0.58
 Carinal pneumonectomies 6(8.9) 3(16.7) 0(0.0) 3(10.7) 0(0.0) 0.49
 Circular resection/anastomosis 24(35.8) 6(33.3) 4(26.7) 12(42.9) 2(33.3) 0.64
 Other 5(7.5) 1(5.6) 2(13.3) 2(7.1) 0(0.0) 0.34

CPB cardiopulmonary bypass, m-CPB modified cardiopulmonary bypass, VV-ECMO veno-venous extracorporeal membrane oxygenation, VA-ECMO veno-arterial extracorporeal membrane oxygenation, BMI body mass index, FEV1% percentage of forced expiratory volume in one second, COPD chronic obstructive pulmonary disease, VATS video-assisted thoracic surgery